Angiotensin II type 1 (AT1) receptor deficiency halts the progression of age-related atherosclerosis in hypercholesterolemia: Molecular link between the AT1 receptor and hypercholesterolemia

Hypertension Research

Volumn 31, Issue 8, 2008, Pages 1495-1497

  Umemoto, Seiji ^a  

^a YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Angiotensin; Atherosclerosis; Hypercholesterolemia; Oxidative stress

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; RENIN INHIBITOR;

AGE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CORONARY ARTERY DISEASE; DISEASE COURSE; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION STATE; PATHOGENESIS; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; RNA STABILITY; UPREGULATION; VASODILATATION;

EID: 55449116733     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1495     Document Type: Editorial

References (21)

1. Wassmann S, Nickenig G: Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J Hypertens Suppl 2006; 24: S15-S21.
2. 1-type angiotensin receptor in oxidative stress and atherogenesis. Part I: Oxidative stress and atherogenesis. Circulation 2002; 105: 393-396.
3. 1 receptor regulation. Circulation 2002; 105: 530-536.
4. Daugherty A, Rateri DL, Lu H, et al: Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004; 110: 3849-3857.
5. Tunon J, Martin-Ventura JL, Blanco-Colio LM, et al: Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors. Vasc Health Risk Manag 2007; 3: 521-526.
6. Keidar S, Attias J, Heinrich R, et al: Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. Atherosclerosis 1999; 146: 249-257.
7. Warnholtz A, Nickenig G, Schulz E, et al: Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999; 99: 2027-2033.
8. Nickenig G, Sachinidis A, Michaelsen F, et al: Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation 1997; 95: 473-478.
9. Solini A, Santini E, Ferrannini E: Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemia. J Hypertens 2005; 23: 367-374.
10. Takai S, Jin D, Sakaguchi M, et al: Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model. Hypertens Res 2004; 27: 517-522.
11. Mueller CF, Nickenig G: Angiotensin II: one driving force behind atherogenesis. Hypertension 2008; 51: 175-176.
12. Wassmann S, Czech T, van Eickels M, et al: Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 2004; 110: 3062-3067.
13. Diz DI: Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging. Hypertension 2008; 52: 37-43.
14. Miyazaki M, Takai S: Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet. Hypertens Res 1999; 22: 49-54.
15. Urata H: Chymase and matrix metalloproteinase. Hypertens Res 2007; 30: 3-4.
16. Eto H, Miyata M, Shirasawa T, et al: The long-term effect of angiotensin II type 1a receptor deficiency on hyper-cholesterolemia-induced atherosclerosis. Hypertens Res 2008; 31: 1631-1642.
17. 1 receptor blockade and atherosclerosis: hopeful insights into vascular protection. Circulation 2000; 101: 1496-1497.
18. Weiss D, Kools JJ, Taylor WR: Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 2001; 103: 448-454.
19. Strawn WB, Chappell MC, Dean RH, et al: Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 2000; 101: 1586-1593.
20. Wassmann S, Hilgers S, Laufs U, et al: Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002; 22: 1208-1212.
21. Fujita M, Yamazaki T, Hayashi D, et al: Comparison of cardiovascular events in patients with angiographically documented coronary narrowing with combined renin-angiotensin system inhibitor plus statin versus renin-angiotensin system inhibitor alone versus statin alone (from the Japanese Coronary Artery Disease Study). Am J Cardiol 2007; 100: 1750-1753.